UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $36.90 Million Holdings in Tenet Healthcare Co. (NYSE:THC)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its position in Tenet Healthcare Co. (NYSE:THC - Free Report) by 7.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 222,030 shares of the company's stock after selling 17,920 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.23% of Tenet Healthcare worth $36,901,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the company. FMR LLC increased its holdings in shares of Tenet Healthcare by 88.0% during the 3rd quarter. FMR LLC now owns 7,700,693 shares of the company's stock worth $1,279,855,000 after purchasing an additional 3,604,161 shares during the period. Marshall Wace LLP increased its holdings in shares of Tenet Healthcare by 7.3% during the 2nd quarter. Marshall Wace LLP now owns 713,979 shares of the company's stock worth $94,981,000 after purchasing an additional 48,626 shares during the period. Farallon Capital Management LLC increased its holdings in shares of Tenet Healthcare by 7.8% during the 2nd quarter. Farallon Capital Management LLC now owns 687,442 shares of the company's stock worth $91,450,000 after purchasing an additional 50,000 shares during the period. Integral Health Asset Management LLC increased its holdings in shares of Tenet Healthcare by 17.6% during the 2nd quarter. Integral Health Asset Management LLC now owns 500,000 shares of the company's stock worth $66,515,000 after purchasing an additional 75,000 shares during the period. Finally, AQR Capital Management LLC increased its holdings in shares of Tenet Healthcare by 35.2% during the 2nd quarter. AQR Capital Management LLC now owns 341,250 shares of the company's stock worth $45,396,000 after purchasing an additional 88,781 shares during the period. Institutional investors own 95.44% of the company's stock.

Wall Street Analysts Forecast Growth

THC has been the topic of several recent research reports. Raymond James lowered shares of Tenet Healthcare from a "strong-buy" rating to an "outperform" rating and set a $195.00 target price on the stock. in a research report on Friday, November 22nd. Barclays lifted their target price on shares of Tenet Healthcare from $171.00 to $190.00 and gave the company an "overweight" rating in a research report on Friday, November 8th. Cantor Fitzgerald lifted their target price on shares of Tenet Healthcare from $168.00 to $177.00 and gave the company an "overweight" rating in a research report on Wednesday, October 30th. UBS Group lifted their target price on shares of Tenet Healthcare from $197.00 to $217.00 and gave the company a "buy" rating in a research report on Wednesday, October 30th. Finally, Wells Fargo & Company lowered shares of Tenet Healthcare from an "overweight" rating to an "equal weight" rating and decreased their target price for the company from $205.00 to $150.00 in a research report on Monday, November 25th. Two analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and three have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus target price of $168.19.

Insider Buying and Selling

In other Tenet Healthcare news, insider R. Scott Ramsey sold 11,599 shares of the company's stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $162.06, for a total value of $1,879,733.94. Following the completion of the sale, the insider now owns 6,324 shares of the company's stock, valued at approximately $1,024,867.44. This represents a 64.72 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Lisa Y. Foo sold 4,000 shares of the company's stock in a transaction that occurred on Thursday, October 31st. The shares were sold at an average price of $155.94, for a total transaction of $623,760.00. Following the completion of the sale, the executive vice president now directly owns 15,566 shares of the company's stock, valued at $2,427,362.04. The trade was a 20.44 % decrease in their position. The disclosure for this sale can be found here. 0.93% of the stock is currently owned by insiders.

Tenet Healthcare Price Performance

Shares of NYSE THC traded up $0.03 during trading on Wednesday, reaching $141.30. The company had a trading volume of 382,559 shares, compared to its average volume of 1,223,514. Tenet Healthcare Co. has a 52 week low of $67.78 and a 52 week high of $171.20. The stock has a market cap of $13.44 billion, a PE ratio of 4.53, a PEG ratio of 0.64 and a beta of 2.06. The company has a debt-to-equity ratio of 2.35, a quick ratio of 1.52 and a current ratio of 1.58. The business's 50 day moving average price is $155.85 and its 200-day moving average price is $148.92.

Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $2.93 earnings per share for the quarter, topping analysts' consensus estimates of $2.33 by $0.60. The business had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.05 billion. Tenet Healthcare had a net margin of 14.91% and a return on equity of 24.05%. Tenet Healthcare's revenue for the quarter was up 1.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.44 earnings per share. Analysts expect that Tenet Healthcare Co. will post 11.38 earnings per share for the current year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.